» Articles » PMID: 26912643

Electroencephalographic Prodromal Markers of Dementia Across Conscious States in Parkinson's Disease

Overview
Journal Brain
Specialty Neurology
Date 2016 Feb 26
PMID 26912643
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

In Parkinson's disease, electroencephalographic abnormalities during wakefulness and non-rapid eye movement sleep (spindles) were found to be predictive biomarkers of dementia. Because rapid eye movement sleep is regulated by the cholinergic system, which shows early degeneration in Parkinson's disease with cognitive impairment, anomalies during this sleep stage might mirror dementia development. In this prospective study, we examined baseline electroencephalographic absolute spectral power across three states of consciousness (non-rapid eye movement sleep, rapid eye movement sleep, and wakefulness) in 68 non-demented patients with Parkinson's disease and 44 healthy controls. All participants underwent baseline polysomnographic recordings and a comprehensive neuropsychological assessment. Power spectral analyses were performed on standard frequency bands. Dominant occipital frequency during wakefulness and ratios of slow-to-fast frequencies during rapid eye movement sleep and wakefulness were also computed. At follow-up (an average 4.5 years after baseline), 18 patients with Parkinson's disease had developed dementia and 50 patients remained dementia-free. In rapid eye movement sleep, patients with Parkinson's disease who later developed dementia showed, at baseline, higher absolute power in delta and theta bands and a higher slowing ratio, especially in temporal, parietal, and occipital regions, compared to patients who remained dementia-free and controls. In non-rapid eye movement sleep, lower baseline sigma power in parietal cortical regions also predicted development of dementia. During wakefulness, patients with Parkinson's disease who later developed dementia showed lower dominant occipital frequency as well as higher delta and slowing ratio compared to patients who remained dementia-free and controls. At baseline, higher slowing ratios in temporo-occipital regions during rapid eye movement sleep were associated with poor performance on visuospatial tests in patients with Parkinson's disease. Using receiver operating characteristic curves, we found that best predictors of dementia in Parkinson's disease were rapid eye movement sleep slowing ratios in posterior regions, wakefulness slowing ratios in temporal areas, and lower dominant occipital frequency. These results suggest that electroencephalographic slowing during sleep is a new promising predictive biomarker for Parkinson's disease dementia, perhaps as a marker of cholinergic denervation.

Citing Articles

Wavelet-Detected Changes in Nocturnal Brain Electrical Activity in Patients with Non-Motor Disorders Indicative of Parkinson's Disease.

Runnova A, Zhuravlev M, Kiselev A, Parsamyan R, Simonyan M, Drapkina O Neurol Int. 2024; 16(6):1481-1491.

PMID: 39585069 PMC: 11587428. DOI: 10.3390/neurolint16060110.


T2 MRI visible perivascular spaces in Parkinson's disease: clinical significance and association with polysomnography measured sleep.

Meinhold L, Gennari A, Baumann-Vogel H, Werth E, Schreiner S, Ineichen C Sleep. 2024; 48(1.

PMID: 39377177 PMC: 11725513. DOI: 10.1093/sleep/zsae233.


Electroencephalogram rhythmic and arrhythmic spectral components and functional connectivity at resting state may predict the development of synucleinopathies in idiopathic rapid eye movement sleep behavior disorder.

Hernandez J, Lina J, Dube J, Lafreniere A, Gagnon J, Montplaisir J Sleep. 2024; 47(12).

PMID: 38497896 PMC: 11632188. DOI: 10.1093/sleep/zsae074.


Sleep spindle density and temporal clustering are associated with sleep-dependent memory consolidation in Parkinson's disease.

Lahlou S, Kaminska M, Doyon J, Carrier J, Sharp M J Clin Sleep Med. 2024; 20(7):1153-1162.

PMID: 38427318 PMC: 11217638. DOI: 10.5664/jcsm.11080.


Cognitive Profile in Parkinson's Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta.

Tufekcioglu Z, Lange J, Pedersen K, Tysnes O, Alves G, Emre M Dement Geriatr Cogn Dis Extra. 2023; 13(1):39-47.

PMID: 38025590 PMC: 10645440. DOI: 10.1159/000534552.


References
1.
HOEHN M, Yahr M . Parkinsonism: onset, progression and mortality. Neurology. 1967; 17(5):427-42. DOI: 10.1212/wnl.17.5.427. View

2.
Svenningsson P, Westman E, Ballard C, Aarsland D . Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 2012; 11(8):697-707. DOI: 10.1016/S1474-4422(12)70152-7. View

3.
Francis P, Perry E . Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Mov Disord. 2008; 22 Suppl 17:S351-7. DOI: 10.1002/mds.21683. View

4.
Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M . EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain. 2008; 131(Pt 3):690-705. DOI: 10.1093/brain/awm322. View

5.
Luckhaus C, Grass-Kapanke B, Blaeser I, Ihl R, Supprian T, Winterer G . Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study. Int J Geriatr Psychiatry. 2008; 23(11):1148-55. DOI: 10.1002/gps.2042. View